Sonsalla PK - Search Results

1

Klotho Protects Dopaminergic Neuron Oxidant-Induced Degeneration by Modulating ASK1 and p38 MAPK Signaling Pathways.

Brobey RK, German D, Sonsalla PK, Gurnani P, Pastor J, Hsieh CC, Papaconstantinou J, Foster PP, Kuro-o M, Rosenblatt KP. Brobey RK, et al. Among authors: sonsalla pk. PLoS One. 2015 Oct 9;10(10):e0139914. doi: 10.1371/journal.pone.0139914. eCollection 2015. PLoS One. 2015. PMID: 26452228 Free PMC article.

2

Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation.

Lee KW, Zhao X, Im JY, Grosso H, Jang WH, Chan TW, Sonsalla PK, German DC, Ichijo H, Junn E, Mouradian MM. Lee KW, et al. Among authors: sonsalla pk. PLoS One. 2012;7(1):e29935. doi: 10.1371/journal.pone.0029935. Epub 2012 Jan 10. PLoS One. 2012. PMID: 22253830 Free PMC article.

3

The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism.

Sonsalla PK, Coleman C, Wong LY, Harris SL, Richardson JR, Gadad BS, Li W, German DC. Sonsalla PK, et al. Exp Neurol. 2013 Dec;250:376-83. doi: 10.1016/j.expneurol.2013.10.014. Epub 2013 Oct 30. Exp Neurol. 2013. PMID: 24184050 Free PMC article.

4

Parkinson's Disease: A Role for the Immune System.

German DC, Eagar T, Sonsalla PK. German DC, et al. Among authors: sonsalla pk. Curr Mol Pharmacol. 2011 Jun 15. Online ahead of print. Curr Mol Pharmacol. 2011. PMID: 21675953

5

Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease.

Sonsalla PK, Wong LY, Harris SL, Richardson JR, Khobahy I, Li W, Gadad BS, German DC. Sonsalla PK, et al. Exp Neurol. 2012 Apr;234(2):482-7. doi: 10.1016/j.expneurol.2012.01.022. Epub 2012 Jan 28. Exp Neurol. 2012. PMID: 22309831 Free PMC article.

6

Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.

German DC, Manaye KF, Sonsalla PK, Brooks BA. German DC, et al. Among authors: sonsalla pk. Ann N Y Acad Sci. 1992 May 11;648:42-62. doi: 10.1111/j.1749-6632.1992.tb24523.x. Ann N Y Acad Sci. 1992. PMID: 1353337

7

1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studies.

Manaye KF, Sonsalla PK, Barnett G, Heikkila RE, Woodward DJ, Smith WK, German DC. Manaye KF, et al. Among authors: sonsalla pk. Brain Res. 1989 Jul 10;491(2):307-15. doi: 10.1016/0006-8993(89)90065-6. Brain Res. 1989. PMID: 2765888

8

The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.

German DC, Nelson EL, Liang CL, Speciale SG, Sinton CM, Sonsalla PK. German DC, et al. Among authors: sonsalla pk. Neurodegeneration. 1996 Dec;5(4):299-312. doi: 10.1006/neur.1996.0041. Neurodegeneration. 1996. PMID: 9117541

9

Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP.

Sanghera MK, Manaye K, McMahon A, Sonsalla PK, German DC. Sanghera MK, et al. Among authors: sonsalla pk. Neuroreport. 1997 Oct 20;8(15):3327-31. doi: 10.1097/00001756-199710200-00027. Neuroreport. 1997. PMID: 9351666

10

The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter.

Speciale SG, Liang CL, Sonsalla PK, Edwards RH, German DC. Speciale SG, et al. Among authors: sonsalla pk. Neuroscience. 1998 Jun;84(4):1177-85. doi: 10.1016/s0306-4522(97)00570-8. Neuroscience. 1998. PMID: 9578404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters